Her Doctor Will Order a $949 Blood Test That Screens for Multiple Cancers. Medicare Will Pay $0 Toward the Test, Leaving Her With the Entire Bill Before Any Coverage Decision in 2029247wallst.com· 4d
A 247wallst.com article by Gerelyn Terzo explains that Grail's $949 Galleri blood test, which screens for cancers lacking standard screening, gets no Medicare coverage: a new law starts payment only in 2029, and its rising age cutoff would leave a 70-year-old woman ineligible even years later, so she pays cash unless TRICARE or employer coverage applies. An FDA advisory panel recently backed the test's safety and effectiveness, but approval and CMS action are still needed.
